Gene therapy in cardiac surgery: Is there a role?

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 5, 2003, Pages 994-997

  Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGININE; DNA; GLYCERYL TRINITRATE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

CARDIOPLEGIA; EDITORIAL; GENE THERAPY; HEART MUSCLE CONTRACTILITY; HEART SURGERY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAFETY; VIRAL GENE DELIVERY SYSTEM;

EID: 0038350970     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.264     Document Type: Editorial

References (13)

1. Sellke FW, Simons M. Angiogenesis in cardiovascular disease: current status and therapeutic potential. Drugs. 1999;58:391-6.
2. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg. 2002;124:28-34.
3. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, et al. Angiogenesis gene therapy: phase 1 assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999;100:468-74.
4. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-23.
5. Logeart D, Hatem SN, Rucker-Martin C, Chossat N, Nevo N, Haddada H, et al. Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther. 2002;11:1015-22.
6. Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ, et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation. 2001;104:131-3.
7. Bridges CR, Burkman JM, Malekan R, Konig SM, Chen H, Yarnall CB, et al. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg. 2002;73: 1939-46.
8. Wang J, Ma Y, Knechtle SJ. Adenovirus-mediated gene transfer into rat cardiac allografts: comparison of direct injection and perfusion. Transplantation. 1996;61:1726-9.
9. Zhu HL, Stewart AS, Taylor MD, Vijayasarathy C, Gardner TJ, Sweeney HL. Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol Ther. 2000;2:470-5.
10. Cable DG, Caccitolo JA, Caplice N, O'Brien T, Simari RD, Daly RC, et al. The role of gene therapy for intimal hyperplasia of bypass grafts. Circulation. 1999;100(19 Suppl):II392-6.
11. Abunasra HJ, Smolenski RT, Yap J, Sheppard M, O'Brien T, Yacoub MH. Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg. 2003;125:998-1006.
12. Laham RJ, Simons M, Sellke FW. Gene transfer for angiogenesis in coronary artery disease. Annu Rev Med. 2001;52:485-502.
13. Shalala D. Protecting research subjects-what must be done. N Engl J Med. 2000;343:808-10.